Brief: AFT Pharmaceuticals Posts FY Revenue Of NZ$208 Million
21/05/2025 21:34
May 22 (Reuters) - AFT Pharmaceuticals FY revenue NZD 208 million. RESOLVED TO DECLARE A DIVIDEND OF 1.8 nz CENTS PER SHARE RESOLVED TO DECLARE A DIVIDEND OF 1.8 nz CENTS PER SHARE FY net income NZD 12 million
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV